Home › Funds › Rock Springs Capital Management LP › CYTK

Rock Springs Capital Management LP position in CYTK

CYTOKINETICS INC · Health Care

Rock Springs Capital Management LP reported holding 201,839 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$13.3M, representing 0.72% of its reported portfolio and ranking #46 among its reported holdings. Rock Springs Capital Management LP has disclosed CYTK holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)201.84K sh
Reported value held$13.30M
Portfolio Weight0.72%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's CYTK position evolved

Rock Springs Capital Management LP first disclosed a stake in CYTK in Q3 2023 at 134,252 shares (US$4.0M). The position peaked in Q2 2026 at 187,980 shares, worth US$16.0M. Across 6 filings, Rock Springs Capital Management LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 201,839 shares valued at US$13.3M — an increase of 13,859 shares quarter over quarter.. Notable position changes include a 27% increase in Q1 2026 (shares rose 29% over the following quarter), a 314% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 134.25K $3.96M New
Q3 2024 206.11K $10.88M New
Q4 2025 35.85K $2.28M New
Q1 2026 45.36K $2.99M Add
Q2 2026 187.98K $16.01M Add
Q3 2026 201.84K $13.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 40 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$323.0M), Polar Capital Holdings Plc (US$227.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Rock Springs Capital Management LP held CYTK?

Rock Springs Capital Management LP has disclosed CYTK holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in CYTK?

As of Q3 2026, Rock Springs Capital Management LP holds 201.84K shares of CYTK (CYTOKINETICS INC), valued at $13.30M, representing 0.72% of its reported portfolio and ranking #46.

Has Rock Springs Capital Management LP been buying or selling CYTK?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in CYTK. The position peaked in Q2 2026 at 187.98K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, Polar Capital Holdings Plc, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.